Stay updated with breaking news from Biogen intl gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After reflecting upon the events of the past twelve months, Patent Docs presents its 16th annual list of top patent stories. For 2022, we identified ten stories that were covered on. ....
The Supreme Court recently agreed to review the enablement standard for genus claims,[1] the first time the Court has considered 35 U.S.C. § 112 since evaluating the standard. ....
On November 15th, the Federal Circuit handed down its opinion affirming all aspects of the District Court's decision in Pharmacyclics LLC v. Alvogen, Inc. The case illustrates once. ....
In United States patent law, in addition to satisfying the requirements for subject-matter eligibility, novelty, enablement, definiteness, and nonobviousness. ....
The Federal Circuit recently granted a panel rehearing and vacated a panel decision between these parties decided earlier this year (see Novartis Pharmaceuticals Corp. v. Accord. ....